Kumari V

References (6)

Title : Organs-specific metabolomics and anticholinesterase activity suggests a trade-off between metabolites for therapeutic advantages of Trillium govanianum Wall. ex D. Don - Kumar_2024_Sci.Rep_14_10675
Author(s) : Kumar D , Kumari V
Ref : Sci Rep , 14 :10675 , 2024
Abstract :
PubMedSearch : Kumar_2024_Sci.Rep_14_10675
PubMedID: 38724667

Title : Graft copolymerization of acrylamide on chitosan-co-chitin and its application for immobilization of Aspergillus sp. RL2Ct cutinase - Kumari_2017_Bioorg.Chem_70_34
Author(s) : Kumari V , Kumar S , Kaur I , Bhalla TC
Ref : Bioorg Chem , 70 :34 , 2017
Abstract :
PubMedSearch : Kumari_2017_Bioorg.Chem_70_34
PubMedID: 27866660

Title : Acetylcholinesterase histochemistry (AChE) - A helpful technique in the diagnosis and in aiding the operative procedures of Hirschsprung disease - Agrawal_2015_Diagn.Pathol_10_208
Author(s) : Agrawal RK , Kakkar N , Vasishta RK , Kumari V , Samujh R , Rao KL
Ref : Diagn Pathol , 10 :208 , 2015
Abstract :
PubMedSearch : Agrawal_2015_Diagn.Pathol_10_208
PubMedID: 26631177

Title : Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation - Sharma_2006_Schizophr.Res_85_73
Author(s) : Sharma T , Reed C , Aasen I , Kumari V
Ref : Schizophr Res , 85 :73 , 2006
Abstract :
PubMedSearch : Sharma_2006_Schizophr.Res_85_73
PubMedID: 16797163

Title : Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study - Kumari_2006_Neuroimage_29_545
Author(s) : Kumari V , Aasen I , Ffytche D , Williams SC , Sharma T
Ref : Neuroimage , 29 :545 , 2006
Abstract :
PubMedSearch : Kumari_2006_Neuroimage_29_545
PubMedID: 16181792

Title : Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study - Aasen_2005_J.Clin.Psychopharmacol_25_311
Author(s) : Aasen I , Kumari V , Sharma T
Ref : J Clin Psychopharmacol , 25 :311 , 2005
Abstract :
PubMedSearch : Aasen_2005_J.Clin.Psychopharmacol_25_311
PubMedID: 16012272